Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube

SELUTION DeNovo subanalysis hints at benefit for balloon-based strategy in high bleeding risk patients

Results of a subanaly...

iPerf concludes clinical trial of novel dual-lumen femoral arterial cannula for cardiopulmonary support

iPerf has announced the c...

Meta-analysis highlights uncertainties over clinical benefit of LAAC compared to oral anticoagulation

A systematic review and m...

Valve surgery study aims to link randomised trial with real-world data

Researchers at the Ic...

Corcym expands mitral repair platform with first-on-human use of Memo 4D Curve annuloplasty system

Corcym has announced ...

CMS updates coverage determination for TAVI

The US Centers for Medica...

Da Vinci 5 surgical system CE marked for adult cardiac surgery

Intuitive has announc...

HighLife to advance its TMVR clinical development programme

HighLife SAS has anno...

Mölnlycke launches Biogel radiation protection gloves to reduce clinician hand exposure during procedures

Mölnlycke Health Care...

Selution SLR gains US FDA approval for coronary ISR

Cordis has announced that...

Texray appoints Ziv Haskal to advisory board

Texray has announced that...

Pulmonary artery denervation shows promise in pulmonary hypertension linked to heart-failure

Patients with pulmona...

DynamX coronary bioadaptor gains approval from Japanese MHLW

Elixir Medical has an...

ESC 2026: DOACs only prevent leaflet thickening in the short term after TAVI

Three months of direc...

PREMIUM trial results not supportive of prasugrel monotherapy at the time of PCI for STEMI

Low-dose prasugrel mo...

Shark Tank cardiovascular innovation competition comes to the Middle East

A shortlist of four f...

IMDS launches microcatheter designed to improve lesion crossing in challenging anatomy

Interventional Medica...

LightningWire transseptal puncture system used in first clinical cases

ElectroWire Medical has a...
SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

Emboliner embolic protection device gains US FDA clearance

Emboline has announce...

First-in-human implant for TriMemo tricuspid annuloplasty technology

Corcym has announced ...

First US patient treated with Saturn TMVR system

InnovHeart has announced ...

Medtronic’s Endurant stent graft system receives CE mark for updated rupture labelling

Medtronic has receive...

AI cardiovascular diagnostic specialist Elucid completes latest financing round

Elucid has raised US$...

ESC 2026: Clopidogrel monotherapy non-inferior to extended DAPT in patients at high ischaemic risk

Clopidogrel monothera...

ESC 2026: Trial results do not support routine LAA closure in all patients undergoing planned cardiac surgery

Routine concomitant closu...

ESC 2026: Coronary clot retriever shown to reduce infarct size in STEMI patients with large thrombus burden

Use of the Envast (Ve...

ESC 2026: CT-derived fractional flow reserve helps reduce rates of invasive angiography in stable CAD patients

Late-breaking results...

GE HealthCare gains CE marking for Photonova Spectra photon-counting CT system

GE HealthCare has achieve...

Medtronic invests in leaflet modification specialist Pi-Cardia

Medtronic has announc...

ESC 2026: Tricuspid repair comes out on top versus medical therapy in trial among high-risk patients

Transcatheter tricusp...

First US commercial cases performed using Protaryx transseptal puncture device

Protaryx Medical has ...

ESC 2026: Simplified definition of MI aims to improve diagnosis and treatment

A universal definition of...

ESC Congress 2026 live blog

Latest-generation Abbott LAA occluder gains CE mark

Abbott has announced CE m...

HighLife Clarity mitral heart valve gains CE mark

HighLife SAS has announce...

Heart Valve Voice highlights opportunities to streamline valve disease care

A new report from the UK ...

US FDA clears AI software for pulmonary hypertension detection

Tempus AI has announced i...

Study highlights challenges in using AI-ECG detection to screen for structural heart disease

Artificial intelligen...

Mohamad Alkhouli named editor-in-chief of JACC: Cardiovascular Interventions

The American College ...

Iron transfusion prior to cardiac surgery reduces the need for blood in anaemic patients

Giving intravenous iron t...

Cold-stored platelets may expand options for addressing bleeding during cardiac surgery

New randomised trial ...

Study suggests alternatives to BMI for predicting risk of cardiovascular disease

The size of a person’...

Jupiter Endovascular appoints Catalin Toma as chief medical officer

Jupiter Endovascular ...

Medtronic executive Shields appointed CEO at Versa Vascular

Versa Vascular, devel...

Obituary: David Taggart

David Taggart, profes...

Treadmill test could uncover previously unseen markers of aortic stenosis

New data from the EAR...

Vexev secures funding to advance US commercialisation of VxWave

Australian medical ro...

Developer of mitral butterfly system acquired by P&F

P&F Products & Fe...

SMARTFLOW trial of AI-powered coronary physiology assessment tool gets underway

AngioInsight has anno...

Pivotal trial of Abbott’s coronary IVL system completes enrolment

Abbott has announced ...

New data available on real-world performance of venous vascular closure system

Haemonetics Corporati...

AI-powered coronary inflammation quantification tool given US FDA de novo authorisation

Caristo Diagnostics has a...

TriNova TTVR system goes head-to-head with Evoque in randomised trial

VDyne has announced t...

TriClip patients to be followed for five years in post-market study

Abbott has initiated ...

BASKET BALL trial of sirolimus-coated balloon in complex coronary disease gets underway

B Braun has announced...

Edwards Lifesciences executive Jaime Wheeler joins CroíValve as CEO

CroíValve, developer ...

Coronary tissue engineered vessel to be studied in first-in-human trial

Humacyte has announced th...

PROMPT-STEMI trial gets green light to begin

Thrombolytic Science has ...

Trial of siRNA therapy in coronary artery disease reports positive initial results

Positive results have bee...

Patient enrolment completed in trial of self-expanding dry-valve TAVI device

Venus Medtech has announc...

Presence of modifiable risk factors associated with greater coronary plaque burden

Having more modifiable ri...

SELUTION DeNovo: DCB strategy may offer promise in complex PCI

Opting for drug-coate...

ICECAP trial of localised cryotherapy treatment for coronary artery disease gets underway

CryoTherapeutics has anno...

ElectroWire Medical receives US FDA 510(k) clearance for LightningWire transseptal puncture system

ElectroWire Medical has a...

US societies call for greater protection against radiation in cath labs

Six leading US health...

Study to use AI-powered imaging software to chart coronary plaque progression

Elucid has announced ...

Stereotaxis completes acquisition of Robocath

Stereotaxis has announced...

No difference in event rates for secondary access strategies during TAVI

Using a transradial appro...

ENHANCE early feasibility study of novel mitral repair system gets underway

Nyra Medical has anno...

First patient joins randomised trial comparing TTVR systems

TRiCares has announce...

IVL matches rotational atherectomy for plaque preparation in severely calcified lesions

Intravascular lithotr...

Study finds favourable delivery outcomes following bioprosthetic aortic valve replacement for women contemplating future pregnancy

Bioprosthetic aortic valv...

Registry data offer real-world comparison of Triclip against randomised trial performance

Early registry data s...
complete-revascularisation

Expert consensus statement updates heart failure definition

A new international exper...

Registry data hint at promise for TMVR system in MAC

Patients with mitral ...

TRIUMPH trial of Laplace TTVR system gets IDE approval

Laplace Interventional ha...

Terumo’s dual view coronary imaging system gets first US use

Terumo Interventional Sys...

Investment supports expansion of CE mark trial of Thubrikar TAVI system

Thubrikar Aortic Valve ha...

TAVI holds up to SAVR at seven years on durability in PARTNER 3 trial

Long-term follow-up d...

Favourable outcomes at one-year with TAVI device for aortic regurgitation

Favourable outcomes w...

DragonFly TMVr system gains CE mark approval for functional MR indication

Valgen Medtech has an...

Ross procedure shows “excellent” outcomes in broad population of patients

The Ross procedure—a ...

CroíValve to expand study of Duo Adapt system following latest funding round

CroíValve has announc...

ViMech procedure offers new hope for treating patients with mechanical aortic valve failure

Fracturing the discs ...

Developer of Carlen TMVr system receives cardiovascular innovation award

Nyra Medical has been...

CHAMPION-AF analysis shows consistent results for LAAC across age groups

In a prespecified sub...

SYMPHONY-PE analysis finds early thrombectomy improves recovery in intermediate-risk PE

Imperative Care has a...
VESALIUS-CV myocardial infarction

Meta-analysis shows comparable rates of mortality at 10-years among left main revascularisation strategies

An individual patient...

Enrolment begins in US feasibility study of A-FLUX reducer system

VahatiCor has announced t...

AI aortic stenosis screening software accepted for FDA pilot programme

AccurKardia has announced...

First routine cases performed using ultrasound treatment for aortic stenosis

Cardiawave has announced ...

PARADIGM trial of DurAVR TAVI valve to begin enrolling at French centres

Anteris Technologies has ...
heart attacks

IPEC2 study sheds light on experiences of women with cardiovascular disease

Global Heart Hub has ...

Four-year data show “favourable” safety and performance of resorbable magnesium scaffold

Teleflex has announced th...

First patients enrolled in study of pulsatile IVL in coronary artery disease

Amplitude Vascular System...

Advanced NanoTherapies secures over US$31 million Series B to deliver dual-drug nanoparticle-coated balloon platform

Advanced NanoTherapies (A...

US study connects climate change to increasing heat-related heart disease nationally

A new study predicts ...

FastWave Medical secures four new international patents

FastWave Medical has ...
flash

EuroPCR 2026: Jupiter Endovascular announces positive results from SPIRARE II pivotal trial

Jupiter Endovascular ...

EuroPCR 2026: Reflow Medical reports “encouraging” six-month results from DEEPER CORONARY study

The first six-month clini...

US FDA clears Acist Medical Systems’ next-generation contrast management solution

Acist Medical Systems...

Philips introduces SmartIQ coronary imaging technology

Royal Philips has ann...

EuroPCR 2026: DynamX bioadaptor demonstrates significantly lower event rates than drug-eluting stent

Elixir Medical has announ...
TAVI

EuroPCR 2026: Routine PCI provides “limited advantage” compared with medical therapy following TAVI

Routine percutaneous ...
SMART trial

EuroPCR 2026: SMART trial three-year data demonstrate superiority for Evolut TAVI system

Medtronic today relea...
VESALIUS-CV myocardial infarction

EuroPCR 2026: VESALIUS-CV trial demonstrates “significant” major adverse event reduction in prior PCI patients with evolocumab therapy

Patients with prior p...
atherectomy

EuroPCR 2026: Orbital atherectomy associated with less acute microvascular injury compared to rotational atherectomy

Orbital atherectomy i...
FRACTURE

EuroPCR 2026: Seismiq 4CE IVL catheter meets endpoints in FRACTURE trial

Results from the pivo...

EmStop announces initiation of CAPTURE-2 IDE clinical trial

EmStop has announced the ...

Trial data put coronary physiology on the cusp of an inflection point

New trial data from A...

From data to decisions: Advancing confidence in DEB therapy

This educational suppleme...

J&J launches Shockwave C2 Aero coronary IVL catheter globally

Johnson & Johnson (J&...

Advertorial: Lifetime management in TAVI: How index valve selection impacts future outcomes

This advertorial is spons...

Bernardo Cortese

Bernardo Cortese (Case We...

Advertorial: Extending the benefits of overhead arm positioning to more patients

This advertorial is spons...

Cardiovascular News – Issue 81 – May 2026 (OUS)

In this issue: New d...

Cardiovascular News – Issue 81 – May 2026 (US)

In this issue: New d...

CorFlow meets performance goals in MOCA II trial

CorFlow Therapeutics ...

SUBCUT HF II trial reports fewer hospital days for HF patients treated for oedema with novel therapy

SQ Innovation has ann...

FASTR pilot trial results published in JACC: Heart Failure

Reprieve Cardiovascular h...

First-in-human trial of next-generation robotic PCI system completes enrolment

Robocath has announce...

J&J enters agreement to acquire Atraverse Medical

Johnson & Johnson (J&...

J Dawn Abbott appointed SCAI president

The Society for Cardi...

New data link tirzepatide to greatly reduced cardiovascular risk in high-risk patients undergoing cardiac procedures

Two new studies show ...

Public interest in TAVI balloons, data show

New research found th...

STEMI patients with COVID-19 were 67% more likely to die at one year than those without coronavirus, registry reveals

Findings from the Nor...

Abbott’s latest-generation Ultreon software gains FDA approval, CE mark

Abbott has received US Fo...

PlaqueTec secures funding to support development of intracoronary database

PlaqueTec, a medtech comp...

Reflow Medical launches new generation of torqueable microcatheters

Reflow Medical has announ...

“Absence of endorsement is not absence of evidence”: CX 2026 peripheral session raises sirolimus-versus-paclitaxel debate

Debate over sirolimus ver...

Abbott unveils “promising” Esprit BTK post-approval study data

Initial data from the E...

Obituary: Eugene Braunwald

Eugene Braunwald, des...

Study compares vascular closure systems in large-bore venous access closure procedures

Haemonetics Corporati...

US FDA grants 510(k) clearance for hybrid coronary imaging system

Conavi Medical has announ...

Medtronic completes CathWorks acquisition and invests in Pulnovo

Medtronic has completed i...

Elucid launches lesion inspection tool for coronary and carotid plaque analysis

Elucid has announced ...

Stereotaxis to acquire Robocath

Stereotaxis has entered i...

Protaryx Medical receives US FDA clearance for proprietary transseptal puncture device

Protaryx Medical has ...

US FDA warns thousands of companies and researchers against suppressing unfavourable trial results

The US Food and Drug Admi...

Heart failure found to be common in people with AF detected during screening

Heart failure is common i...

New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation

The 90-day results of...

Trilogy valve gets US commercial launch

JenaValve Technology ...

Prostyle M mitral valve system gets first use in clinical study

The first implant of ...

Randomised trial of 8Fr TAVI system gets underway

MiRus has announced e...

Vascade MVP XL vascular closure system gets expanded labelling

Haemonetics Corporati...

US FDA approves SUPPORT II trial of pVAD system for high-risk PCI

Supira Medical has announ...

Stereotaxis announces US FDA clearance and launch of Synchrony system

Stereotaxis has announced...

Latest data from TRISCEND II trial look at crossover patients treated with Evoque system

Edwards Lifesciences ...

Electronic notifications “improve timely evaluation of structural heart disease”

Medtronic has released da...

Topaz TTVR system given green light for US IDE trial

TRiCares has announce...

Trial of renal denervation plus staged PCI in patients with multivessel coronary disease and hypertension launches

Medtronic has announc...

VDyne TTVR system approved for US IDE clinical trial

VDyne has announced t...

SirPAD: Primary results confirm safety and efficacy of sirolimus-coated balloon in PAD

In the SirPAD trial, ...

Clinical trial finds comparable performance between TAVI embolic protection devices

Results from the PROT...

Roxana Mehran named ACC president

The American College ...

LAA closure device non-inferior to blood thinners in lowering stroke risk and death for some AF patients

For patients with non...

Performance of AI-powered physiologic assessment tool shows promise in ALL-RISE trial

An artificial intelli...

FAST III confirms non-inferiority of vFFR to wire-based lesion assessment

Results of the FAST I...

Evolocumab reduces risk of cardiac events in patients with no known atherosclerosis and diabetes

The cholesterol-lower...

HI-PEITHO finds catheter-based procedure improves pulmonary embolism outcomes

Patients who underwen...

Philips launches latest generation interventional guidance platform

Royal Philips has ann...

First baby treated with Lifeline stent system

Starlight Cardiovascu...

Medical societies call for new standard in radiation protection

Nine medical societies ar...

First patient treated in USA with next-generation sutureless aortic valve

Corcym has announced the ...

Cardiovascular News – Issue 80 – March 2026

In this issue: New d...

Trilogy valve gains US FDA premarket approval

JenaValve Technology ...

Roxana Mehran

Roxana Mehran is an inter...

Advertorial: New evidence investigates the impact of Shockwave IVL, Wolverine™ Cutting Balloon and OPN® NC in severely calcified coronary lesions

This advertorial is spons...

Funding secured to accelerate study of mitral posterior leaflet management system

Polares Medical has close...
SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

Emboline secures funding to support launch of embolic protection system

Emboline has closed U...

First patient treated in US trial of renal pelvic denervation technology

Verve Medical has announc...

CRT 2026: Late-breaking data highlight growing adoption of angiography-derived fractional flow reserve

First-look data on th...

Valcare Medical strengthens board with dual appointment

Valcare Medical has annou...

Mitria Medical’s Subvalvular Spacer implanted under compassionate use

Mitria Medical has announ...

First ACC/AHA acute PE guidelines provide “roadmap” for management

A new severity-based ...

THT 2026: HFrEF patients undergoing baroreflex activation therapy see shift in LVEF

Initial six-month outcome...

Mike Buck joins TTVR developer VDyne as CEO

VDyne has announced t...

THT 2026: Autologous cell therapy may curb pathological ventricular remodelling in chronic ischaemic HFrEF patients

BioCardia has reporte...

THT 2026: Study of smart implant for heart failure decongestion reports first-in-human data

Relief Cardiovascular...

Evolut Low Risk investigators probe increasing reintervention rate beyond six years

Latest data from the ...

Abbott’s next-generation PA pressure reader gains US FDA approval

Abbott has announced ...

Paradise renal denervation system available in Japan

The Paradise ultrasou...

US FDA approves CT angiography system for visualising cardiac conduction system

Cara Medical has anno...

EAPCI Summit: Registry seeks to bridge ACS gender gap

Preliminary results from ...
heart attacks

EAPCI Summit: Serbian registry offers new insight on spontaneous coronary artery dissection

Stent implantation ma...

Symplicity Spyral renal denervation system gains reimbursement approval in Japan

Medtronic has announc...

EAPCI Summit: Rise in primary PCIs has not shifted the dial on acute MI mortality

An increase in the number...

EAPCI Summit: One in five patients can be discharged on day of TAVI procedure

Same-day hospital dischar...

Obituary: Dominique Vervoort

Figures from across t...

Elumn8 Medical, formerly Simpson Interventions, closes financing round

Elumn8 Medical—former...

Cardiovascular intelligence software platform gains US FDA clearance

Retia Medical has ann...

PERTs improve outcomes but “magic formula” does not exist, LINC audience hears

In a session at the 2...

Obituary: Thomas J Fogarty

Thomas J Fogarty, the wor...

CRF to launch Complex Coronary Summit in 2027

The Cardiovascular Resear...
heart attacks

PICCOLETO IV trial investigating SAPT after DCB-PCI in high-risk population launches

Investigators have an...

AI-based ECG technology may improve aortic stenosis mortality prediction

AccurKardia has announced...

GAMEFILM registry expands to include retired NBA and NHL athletes

Heartflow has announced a...

First case of transcatheter mitral annuloplasty performed in AMEND EFS trial

The first procedure h...

Next-generation contrast management system gets European market launch

Acist Medical Systems...

Funding secured to advance clinical programme for implantable heart failure device

Berlin Heals has announce...

Peijia Medical seeks EU MDR approval for GeminiOne TEER system

Peijia Medical has fo...

Statins likely not the cause of most side effects listed on packaging leaflets

A major review of adv...

Off-pump CABG, in experienced hands, reduces perioperative complications with similar long-term survival

Coronary artery bypas...

STS data suggest surgeons have begun to shift the tide in TAVI explant mortality

Operative mortality f...

TricValve bicaval valve system gains EU MDR certification

P&F Products and ...

Investigator-led initiative supporting PE research launched

AngioDynamics and The PER...

UK’s NICE recommends implantable device for remote heart failure monitoring

The UK’s National Ins...

Jupiter Endovascular completes enrolment in SPIRARE II pivotal trial

Jupiter Endovascular ...

CADScor system achieves EU MDR certification

Acarix has announced ...
TRIOMPHE

Endospan announces one-year data from TRIOMPHE IDE study

Endospan today announ...

STS 2026: Long-term comparison of multi-arterial CABG strategies finds similar survival rates

Two of the most commo...

Medtronic exercises its option to acquire CathWorks

Medtronic has announc...

GE HealthCare’s Allia Moveo gains FDA and CE mark approvals

GE HealthCare has ann...

Badhwar elected STS president with focus on “excellence, evidence and impact”

The Society of Thorac...

STS and ACC partner on new cardiac certification scheme

The US healthcare accredi...

First usage of ultrasound system to detect brain emboli in PFO patients

BURL Concepts has ann...

Robocath launches FIH clinical study of second-generation robotic system in coronary artery disease

Robocath has announce...

Da Vinci 5 surgical robot gains new clearances for cardiac procedures

Intuitive has announc...

CVRx announces initiation of BENEFIT-HF trial of Barostim device in “significantly expanded population”

CVRx recently announc...

Study validates AI tool’s ability to detect valvular disease and ventricular dysfunction

AISAP has announced t...

Evolocumab cuts MACE risk, even in patients with no prior events

Use of the PCSK9 inhi...

HighLife TMVR system gains CE mark

HighLife SAS has anno...

Demonstrating the case for inpatient prehab and rehab for advanced heart failure

Frailty has become a ...

Medtronic invests in Anteris Technologies, maker of DurAVR system

Medtronic has complet...

Gene therapy: A new solution to coronary graft failure?

Nawwar Al-Attar (Glas...

First-in-man VECTOR procedure offers new approach for preventing coronary obstruction

The first-in-man use ...

Trisol shares early results of TTVR system in severe to torrential TR

Trisol Medical has an...

Trial of polymer-free DES in STEMI PCI enrols first patients

Concept Medical has annou...
Extreme temperature

Societies urge action on environmental stressors contributing to cardiovascular disease deaths

Leading cardiovascular so...

TRiCares secures EIB loan to support clinical study of Topaz TTVR system

TRiCares has secured ...

Boston Scientific announces agreement to acquire Penumbra

Boston Scientific and...

Conavi Medical secures funds to advance next-generation intravascular imaging platform

Conavi Medical has comple...
coronary artery bypass

Bypass surgery may offer longer-term benefit to women with severe coronary disease compared to PCI

Women with chronic se...

YorLabs’s intracardiac imaging system used for first time following US FDA clearance

YorLabs has announced the...

Gene therapy trial seeks to reduce coronary graft failure

The first patient has...

Edwards drops JenaValve acquisition after FTC injunction upheld

Edwards Lifesciences ...

Haemonetics acquires vessel closure specialist Vivasure Medical

Haemonetics Corporati...

Marshall Mohr joins board at Capstan Medical

Capstan Medical has a...

Study shows predictor of adverse events after valvular interventions

Reduced tricuspid annular...

Robotic surgical system adds 5mm instruments for use in small structures

SS Innovations Intern...

Sonico-CX coronary IVL system gains CE mark

Spectrumedics Medical...

Gore enters into agreement for acquisition of Conformal Medical

WL Gore & Associa...

Transseptal TMVR system gains US FDA approval

Edwards Lifesciences ...

Cardiovascular News’ most-read stories of 2025

Which stories, features a...

Non-invasive screening system “actively detects elevated LV end-diastolic pressure”

Ventric Health has an...

Relief Cardiovascular appoints former Endotronix CEO as chairman

Relief Cardiovascular, a ...

Delivery system for PDA closure in premature infants gains regulatory approvals

Abbott has received US Fo...

OpusOne pVAD enters first-in-human study

Enginprime Medical ha...

First-in-human trial of regenerative coronary bypass graft to commence

Medical 21 has received r...

AI platform identifies “critical mass” threshold of non-obstructive plaque in coronary artery disease

Latest data from the inte...

Philips to acquire SpectraWAVE

Royal Philips has ent...

US FDA clears pivotal trial for bicaval valve system for TR

P&F USA, the US s...

Feasibility trial shows promising results for renal assist device

Roivios has announced pro...

Dedicated TAVI system for AR gains NMPA approval in China

Peijia Medical has an...

Coronary thrombectomy system gains US FDA clearance

Vesalio has announced US ...

Aquapass fluid overload management system gains marketing approval in Israel

Aquapass has received Isr...

EACVI: Study sheds light on prevalence of valvular heart disease amongst cancer patients

Valvular heart disease, i...

Analysis shows predictive value of FFR-CT for cardiovascular events in angina patients

Reduced coronary blood fl...

RoseDoc system gets first-in-human use in tricuspid valve replacement cases

Allmed Solutions has ...

Premarket notification submitted to FDA for SSi Mantra surgical robotic system

SS Innovations Intern...

Tenecteplase non-inferior to alteplase in thrombolytic success for valve thrombosis

Tenecteplase may be a saf...

Non-invasive ultrasound therapy for aortic stenosis gains CE mark

Cardiawave has received C...

US FDA clearance for Hotwire transseptal access system

Atraverse Medical has rec...

AltaValve early feasibility study reports out to one year

One-year outcomes fro...

Hypertension drug baxdrostat accepted for priority review by US FDA

AstraZeneca’s new drug ap...

“Durable” valve performance seen with early generation transapical TMVR system

Five-year results of ...

Largest dataset from ALIGN-AR trial shows favourable outcomes with Trilogy valve

Data from 700 patient...

Procyrion appoints Andrew Davis to lead therapy development

Procyrion has appoint...

VisCardia secures funding to support RECOVER-HF trial

VisCardia has secured US$...

New imaging tool launched to aid coronary interventions

Siemens Healthineers has ...

Akura Medical closes series C financing

Akura Medical has sec...

RSNA 2025: Abdominal obesity associated with harmful changes in heart structure

A new study using adv...

Siemens Healthineers launches AI-powered imaging system, Optiq AI

Siemens Healthineers ...

Latest data from Dragonfly pivotal studies shared at PCR London Valves

Latest clinical data ...

Investment to accelerate development of VenstraMedical’s pVAD system

VenstraMedical has an...

US FDA clears TELLTALE TAVI guidewire system

Transmural Systems has ob...

“We need to look at the totality of evidence”: VIVA panellists examine SWEDEPAD findings

A focused session at ...

Advertorial: Trial of drug-eluting balloon technology “game-changing” for PCI in de novo coronary lesions

This advertorial is spons...

Vascular complications uncommon in study of latest-generation arterial closure device

No major vascular com...

Music therapy improves patient experience during PCI and shows promise for fine tuning cardiovascular parameters

Playing music to pati...

Philips previews AI-powered guidance system for mitral TEER procedures

Royal Philips has int...

PARADIGM trial of DurAVR TAVI valve gets US FDA green light

Anteris Technologies ...

Trilogy TAVI valve reaches 1,000 commercial cases

JenaValve has announc...

First clinical procedures performed using AI TAVI guidance software

Caranx Medical has announ...

CryoTherapeutics, SpectraWAVE and CRF partner for ICECAP clinical study

CryoTherapeutics has anno...

Librexia ACS trial of factor Xia inhibitor in ACS patients ended early

Bristol Myers Squibb and ...

PCR London Valves 2025 hears latest data from LANDMARK trial of Myval TAVI device

Meril Life Sciences h...

Poll highlights rising concern for radiation exposure among interventionists

A new US-wide poll announ...

Cost analysis suggests benefit of early TAVI in asymptomatic aortic stenosis

Edwards Lifesciences ...

Low rates of PPM seen following TAVI in small aortic annuli with DurAVR system

Thirty-day clinical o...

TARGET study demonstrates TR reduction with Cardiovalve system

Venus Medtech has ann...

FAME 3: PCI shown to be more cost effective than CABG

Economic analysis of ...

Cardiovascular News – Issue 79 – November 2025 (US)

In this issue: Get u...

Cardiovascular News – Issue 79 – November 2025 (OUS)

In this issue: Get u...

LAA closure fails to achieve non-inferiority versus standard care in AF patients with high stroke and bleeding risks

For older people with irr...

AHA 2025: Ataciguat slows progression of aortic valve calcification

Kardigan has announced po...

New data point to predictive value of plaque volume for long-term events in coronary artery disease patients

Heartflow has announc...

AHA 2025: Polypill shown to be effective in HFrEF patients

Among patients with h...

AHA 2025: PCKS9 inhibitor use reduced LDL levels after heart transplant surgery

The PCSK9 inhibitor a...

Native vessel PCI “no longer the default strategy” for patients with previous CABG

Should interventionalis...

Alteplase fails to impact outcomes in STEMI patients with high thrombus burden

Low-dose intracoronary ...

Tendyne system shows promise in patients with mitral annular calcification

A trial of transcathete...

Study of laser IVL system completes enrolment

FastWave Medical has ...

Transseptal TMVR system shows promise in patients unsuited for surgery or TEER

Results of a pivotal cl...

Latest data “reassuring” on safety and effectiveness of transcatheter tricuspid interventions

Analysis of data from t...

Patrick Myers

Serving as the secretary ...

Advertorial: Valve choice in the new chapter of TAVI

This advertorial is spons...
heart attacks

Report seeks to level the playing field for women in heart valve care

For Jacqueline Lewis, a f...

Advertorial: No fear of dissection: How dissections can support positive outcomes in DCB therapy

This advertorial is spons...

Virtue trial of sirolimus-eluting balloon enrols first patients

Orchestra BioMed Hold...

AI helps smartwatch ECG sensors to detect structural heart disease

An artificial intelli...

AtriCure announces treatment of first patient in BoxX-NoAF clinical trial

AtriCure has announced th...

CMS finalises coverage decision for renal denervation systems

The Centers for Medicare ...

Terumo announces US FDA clearance for OpusWave imaging system

Terumo Interventional Sys...

Interim RAPID-PE study reveals ‘excellent’ safety data in first 50 patients

Prespecified interim ...

TCT 2025: Deferring treatment of non-culprit lesions “remains an option” for STEMI in multivessel disease

New data suggest that...

Semaglutide prevents cardiovascular events regardless of weight loss

Analysis of the SELEC...

TCT 2025: Coronary bioadaptor shows reduction in events compared to DES at two years

Latest clinical resul...

TCT 2025: TAVI continues to match up to surgery at seven years in PARTNER 3 trial

Latest results from t...

TCT 2025: “Site-less” trial opens window on prevalence of heart valve disease across USA

A “site-less” trial t...

TCT 2025: STORM-PE finds mechanical thrombectomy superior to anticoagulation alone

The use of mechanical...

TCT 2025: Trials find comparable outcomes for IVL alternatives in calcified coronary disease

Cutting balloon angio...

TCT 2025: Three-year results demonstrate “durable” impact of radiofrequency renal denervation

Medtronic has announc...

TCT 2025: Selution SLR meets non-inferiority in de novo and in-stent restenosis trials

Cordis has announced ...

Smart implant for pressure-guided heart failure decongestion wins TCT 2025 Shark Tank prize

Relief Cardiovascular...

Protaryx Medical submits premarket notification to US FDA for transseptal puncture device

Protaryx Medical has ...

Medtronic launches “extra stiff” TAVI guidewire

Medtronic has announc...

TCT 2025 live blog

Sustained remodelling achieved at two years with AccuCinch LV restoration system

Ancora Heart has anno...

Study to compare non-invasive HF monitoring system with implant

Ventric Health has co...

First-in-human study of Cardiac Leaflet Enhancer reaches enrolment milestone

Nyra Medical has anno...

Medtronic partners with DASI Simulations to bring AI modelling technology to US TAVI centres

Medtronic and DASI Simula...

AI algorithm for MAC detection and quantification gains US FDA approval

Bunkerhill Health has rec...

Intensive cholesterol lowering fails to shift the dial on vein graft failure

Intensive LDL cholest...

Pivotal trial of tricuspid annuloplasty system to commence following IDE approval

Micro Interventional Devi...

Light-reactive technology offers promise for preventing vein graft failure

Treating vein grafts ...

Up to half of patients may experience AF after coronary surgery, but burden is low

A prospective study i...

Enrolment completed in CONFORM pivotal trial of LAAO system

Conformal Medical has...

EACTS 2025 hears new data on aortic arch remodelling device

Data from the AMDS PERSEV...

Medtronic’s Endurant receives US FDA labelling approval to remove rAAA treatment warning

Medtronic recently an...

Dapagliflozin does not add to quality-of-life benefit gained from TAVI

Patients receiving dapagl...

“Abbey Bear” seeks to demystify LVAD treatment for young heart failure patients

Abbott has unveiled a...

Jupiter Endovascular secures funds to continue development of TFX platform

Jupiter Endovascular ...

SpectraWAVE appoints Jonathan Hill as chief medical officer

SpectraWAVE has annou...

SSi Innovations prepares FDA submission for Mantra surgical robot

SS Innovations Intern...

US FDA approves IDE for investigation of FLOWer embolic protection device

AorticLab has announced t...

Interim results of FIH study of CorWave LVAS shared at HFSA 2025

CorWave has announced the...

Taho Pharma submits new drug application to US FDA for apixaban oral dissolving film

Taho Pharmaceuticals has ...

Elixir Medical’s LithiX HC-IVL system gets full market release

Elixir Medical has announ...

Omron blood pressure monitors exceed 400 million in sales

Omron Healthcare has ...

Medtech Insights: Edwards’ Brüls outlines company’s move to specialise on structural heart disease

When Cardiovascular N...

DEEPER CORONARY study of Spur Elute retrievable scaffold system completes enrolment

Reflow Medical has announ...

One in three deaths globally linked to cardiovascular disease

Cardiovascular diseases r...

Hearflow’s next-generation Plaque Analysis algorithm gains US FDA clearance

Heartflow has receive...

BioCardia announces top line data from trial of CardiaAMP cell therapy procedure

BioCardia has announc...

UK survey highlights wealth disparities in heart valve care

Research published by Hea...

SCAI initiative seeks to establish faster diagnosis of cardiogenic shock

A new initiative by the S...

New preclinical data show early patency of coronary tissue engineered vessel

Humacyte has announced th...

SYMPHONY-PE trial demonstrates positive efficacy, efficiency, and safety results

Imperative Care has annou...

J-Valve TAVI system granted approval for treatment of aortic regurgitation in China

Genesis MedTech's structu...

CORE-MD consortium announces recommendations on clinical assessment of high-risk medical devices

The CORE-MD—Coordinating ...

Mount Sinai establishes research centre focusing on AI in the cath lab

Mount Sinai Fuster He...

Multicentre study to assess outcomes of TAVI and SAVR in bicuspid valves

Cedars-Sinai (Los Ang...

Cardiac Dimensions appoints William T Abraham as chief medical officer

Cardiac Dimensions ha...

First patient receives Sutra Hemi-valve mitral repair system

Sutra Medical announced t...

Neurescue device receives CE mark for treating non-shockable cardiac arrest

Neurescue has announced C...

First implantations of RoseDoc tricuspid valve replacement system begin in India

The first stage of th...

Rethinking dissections: How drug-coated balloons may turn risk into an opportunity

Interventional cardio...

Laza Medical announces milestone in use of its AI-based heart model for ultrasound-guided procedures

Laza Medical has anno...
Tria

Tria mitral valve launches in India

Foldax has announced ...

Timing DAPT based on risk score may reduce risk of adverse events

Tailoring dual antipl...

ESC 2025: AQUATIC trial cautions against use of aspirin in chronic coronary syndrome patients receiving anticoagulation

New evidence cautions...

Dipti Itchhaporia

Serving as the president ...

Imperative Care receives FDA 150k clearance for Symphony thrombectomy system

Imperative Care has a...
shruthi narayan

Shruthi Narayan appointed president of Penumbra

Penumbra has announce...

Symplicity Spyral renal denervation system gains Japanese PDMA approval

Medtronic has announced i...

FDA begins ‘real-time’ reporting of adverse event data

The Food and Drug Adm...

ESC 2025 hears long-term data from DANGER-SHOCK trial

Routine use of the Impell...

New focus on education needed to improve uptake of intracoronary imaging

Better provision of han...

ESC 2025: Studies shed new light on antiplatelet therapy after CABG surgery

New evidence offers f...

ESC 2025: Baxdrostat shows promise in lowering blood pressure in uncontrolled and resistant hypertension

Results from the ​BaxHTN ...

ESC 2025: DUAL-ACS trial finds “less is more” for DAPT after acute MI

A three-month course ...

SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes

Drug-coated balloons ...

ESC 2025: REBOOT prompts rethink on use of beta blockers in uncomplicated MI

Beta-blocker therapy appe...

ESC 2025: Trial results add digitoxin as an option for patients with advanced heart failure

Digitoxin reduced the...

Roxana Mehran receives ESC Gold Medal

Roxana Mehran (Icahn ...

ESC 2025: Guideline revisions include new TAVI age threshold

Latest randomised tri...

Navitor TAVI valve picks up expanded CE mark for low-risk patients

Abbott’s Navitor transcat...

ESC 2025: “Minimalist” approach to TAVI may be an option for most patients

A “minimalist” transc...

Evolut TAVI systems gain US FDA approval for redo-TAVI procedures

Medtronic has received US...

Advertorial: Expanded indications for Prevail DCB broaden options for complex PCI, including bifurcations

This advertorial is spons...

Cardiovascular News – Issue 78 – September 2025 (US)

In this issue: Globa...

Cardiovascular News – Issue 78 – September 2025 (OUS)

In this issue: Globa...

Favourable blood pressure and haemodynamic effects seen with AVIM therapy

Orchestra BioMed has anno...

Paradise ultrasound renal denervation system gets approved for use in Japan

Recor Medical has ann...

Agent DCB to be studied in de novo coronary trial including bifurcations and long lesions

Boston Scientific has ini...

Conformal Medical closes latest financing round

Conformal Medical has...

US blood pressure guidelines bump up recommendation for renal denervation

New guidelines from t...

Spironolactone fails to lower cardiovascular risk in dialysis patients

A large international stu...

Image-guided crossing and re-entry system used for first time in coronary CTO trial

Simpson Interventions has...

Heartflow raises more than US$364 million through initial public offering

Heartflow, a developer of...

Reprieve Cardiovascular announces funding and trial enrolment milestones

Reprieve Cardiovascular h...

APC Cardiovascular acquires Precision Surgical

APC Cardiovascular has an...

Gentuity and GE HealthCare collaborate to improve availability of imaging systems

Gentuity has announced an...

Wearable patch may speed up diagnosis of atrial fibrillation after cardiac surgery

The use of a wearable ele...

Total artificial heart system gains entry to US FDA advisory programme

Bivacor has announced tha...

Competition concerns put Edwards’ JenaValve acquisition in jeopardy

The US Federal Trade ...

Japanese registry data support TEER in atrial functional mitral regurgitation patients

Patients with atrial func...

ShortCut leaflet splitting device granted add-on payment designation by CMS

Pi-Cardia has announc...

First patients enrolled in MAGICAL-SV study of sirolimus DCB in small coronary vessels

Concept Medical has annou...

Orchestra BioMed secures additional capital from funding partners

Orchestra BioMed has ...

Sutureless aortic valve used for first time in RAVR procedure

Corcym has announced ...

Latest trial results offer promise of sustained treatment for the heart’s “forgotten valve”

Two-year results of t...

SRS 2025: Intercontinental robotic cardiac surgery completed using SSi Mantra 3 system

SS Innovations Intern...

Trial shows potential of low-level microcurrent stimulation in heart failure

Results of the C-MIC ...

Surgeons perform pioneering robotic-assisted BiVAD implantation

King Faisal Specialist Ho...
Medical devices MHRA

MHRA announces UK medical device regulation amends

The Medicines and Hea...

First patient enrolled in continued access protocol trial of heart transplant technology

Xvivo has announced that ...

AtriCure completes enrolment in trial assessing stroke prevention with AtriClip device

AtriCure has announced th...

Results of DECIDE registry presented at SCCT 2025

Heartflow has announced n...

Ceryx Medical closes latest funding round

Ceryx Medical has announc...

AI model able to predict onset of valve regurgitation

An artificial intelligenc...

Heart failure and AF increase risk of death or hospitalisation for patients undergoing transcatheter mitral repair

Patients with heart f...

Preliminary data “encouraging” for biorestorative coronary bypass conduit

Xeltis has announced prel...
heart attacks

Graft occlusion after CABG seen more often in female patients

Early bypass graft oc...

TAVI shown to have a lower carbon footprint than SAVR

Patients’ age, surgical r...

US FDA gives approval to commercialise AI software to guide transcatheter procedures

Caranx Medical has an...

Trial comparing TAVI and SAVR in aortic regurgitation enrols first patients

JenaValve has announced t...

CMS recommends coverage for renal denervation for hypertension

The US Centres for Medica...

CE mark approval for Biosensors’ Imperia THV delivery system

Biosensors International ...

Finerenone approved to treat heart failure patients

Bayer has announced t...

US patent issued for algorithm to predict renal denervation response

Geneticure has announ...

UK NICE recommends pulsed field ablation as AF treatment option

The UK’s National Institu...

Germany sees “exponential” growth in tricuspid interventions

Transcatheter therapies f...

First patient receives CorWave left ventricular assist system

CorWave has announced the...

CorFlow Therapeutics gains US FDA approval for IDE trial

CorFlow Therapeutics ...

Merit Medical names Martha Aronson as new president and CEO

Merit Medical recently an...

First patient treated in trial of multi-organ denervation for uncontrolled hypertension

Medtronic has announced t...

VitalFlow ECMO system gains CE mark approval

Medtronic has announc...

EARLY TAVR: Analysis looks at trial’s outcomes based on guideline recommendations

New analysis of the EARLY...

First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease

The first US procedur...

CroíValve secures funding from Horizon Europe EIC Accelerator

CroíValve, developer of t...

New York Valves hears 30-day results of low-profile TAVI valve

Thirty-day results of...

Global study shows widening disparity in mitral valve disease outcomes

Degenerative mitral v...

Teleflex completes acquisition of Biotronik’s Vascular Intervention business

Teleflex today announced ...

First patient enrolled in EASE HF2 study of Intershunt technology for HFrEF treatment

InterShunt Technologies h...

One-year results show positive safety and haemodynamic performance for biopolymer surgical mitral valve

Foldax has announced ...

Improved survival seen following TAVI explant compared to redo procedures

Analysis of real-world US...

SEISMIC-HF I study assesses use of non-invasive HFrEF management technology

Cardiosense has annou...

Vivasure Medical submits premarket approval for PerQseal Elite vascular closure device

Vivasure Medical has ...

Evoque tricuspid valve replacement system gains Health Canada approval

Edwards Lifesciences ...

First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE

AngioDynamics has announc...

Enrolment milestone met in CORCINCH-HF pivotal trial

Ancora Heart has anno...

ADA 2025: Semaglutide taken orally shown to reduce cardiovascular risk in type 2 diabetes patients

Research presented at the...

Study intensifies call for randomised trial in patients with bicuspid aortic stenosis

The results of a retr...

Stroke rates diverge among TAVI and surgery patients at five years in pragmatic trial

Long-term results of ...

Ceryx Medical to develop physiologically responsive pacemaker following funding boost

Ceryx Medical has announc...

New medical device reporting requirements come into effect in the UK

New regulations have come...

Prevencio granted patents to protect proprietary coronary artery disease blood test platform

Prevencio has been grante...

Enrolment completed in ATHENS-HF first-in-human study of Adona interatrial atrial shunt

Adona Medical has ann...

MedHub-AI and Terumo partner to distribute AI-powered FFR system in Japan

MedHub-AI has announc...

Funding round allows completion of RESPONDER-HF trial of Corvia atrial shunt

Corvia Medical has an...

EMPACT-MI analysis “reassuring” on use of empagliflozin in patients with poor kidney function

Empagliflozin preserv...

Aventus thrombectomy system gains FDA clearance for PE treatment

Inquis Medical has announ...

Penumbra’s STORM-PE randomised trial completes enrolment

Penumbra has announce...

TRANSFORM II study of sirolimus DCB completes patient enrolment

Enrolment has been comple...

Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology

Atraverse Medical has ann...

EuroPCR 2025: Thirty-day results show promise for Lux-Valve Plus TTVR system

Jenscare has announce...

Surgical ablation during CABG carries survival advantage for patients with preexisting AF

Medicare patients with at...

Tria polymer mitral valve gains Indian CDSCO approval

Foldax has announced that...

Trial of DCB and scaffold technologies enrols first CTO-PCI patients

Biotronik has announced t...

FastWave Medical announces successful 30-day first-in-human data on Sola IVL technology

FastWave Medical has ...

Boston Scientific withdraws TAVI devices from the market

Boston Scientific has ann...

EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms

New data comparing th...

Abbott’s Tendyne TMVR system gains US FDA approval

Abbott has announced ...

Prevail DCB gains expanded CE mark indications

Medtronic has received CE...

EuroPCR 2025 hears early outcomes of Topaz TTVR system

TRiCares has announce...

EuroPCR 2025: DynamX coronary bioadaptor “durable” through three years

Elixir Medical has an...

EuroPCR 2025: Three-year data available for Freesolve resorbable magnesium scaffold

Thirty-six-month follow-u...

Medtronic TAVI platforms gain CE mark for expanded redo TAVI indication

Medtronic has announc...

EuroPCR 2025: Sustained reduction in TR seen at two years with Triclip in real-world data

Two-year outcomes fro...

Tackling unacceptable mortality in aortic stenosis: A call to expand TAVI access

Transcatheter aortic valv...

EuroPCR 2025: Search for suitable candidates for cerebral embolic protection continues

A pooled, individual pati...

Trial seeks to demonstrate benefit of ultra-low dose X-ray technology

Royal Philips has ann...

EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days

Thirty-day primary en...

Cordis initiates SELUTION global coronary registry of coronary DCB

Cordis has announced the ...

Philips introduces VeriSight Pro 3D ICE catheter in Europe

Royal Philips has tod...

Cytokinetics shares topline results from MAPLE-HCM trial

Cytokinetics has announce...

FAVOR III identifies major risk factors of cardiovascular events after PCI

New findings from the...

“Urgent need” to move away from lead in mitigating cath lab radiation exposure

With an increasing fo...

Advertorial: New data underline the importance of lifetime management of aortic stenosis patients

This advertorial is spons...

Mayra Guerrero

Mayra Guerrero (Mayo Clin...

Cardiovascular News – Issue 77 – May 2025

In this issue: Lance...
TRIOMPHE

Endospan announces positive 30-day outcomes from TRIOMPHE IDE study

Endospan recently ann...

Early analysis of BIOPATTERN trial offers insights on make-up of coronary plaque

PlaqueTec has announced n...

Heartflow shares two-year data from FISH&CHIPS study

Heartflow has announc...

Inquis Medical’s Aventus thrombectomy system found safe and effective for patients with PE

Inquis Medical recently a...

FastWave Medical to commence coronary feasibility study of laser IVL system

FastWave Medical has secu...

SCAI names Srihari S Naidu as president

The Society for Cardi...

SCAI 2025: Early TAVI “should be preferred to clinical surveillance in all age groups”

Analysis from the EARLY T...

SCAI 2025: Novel leaflet modification technique shows promise in reducing LVOT obstruction in mitral valve replacement

A novel technique to ...

SCAI 2025: Stenting “improves long-term survival” for patients undergoing CTO PCI

In patients undergoing ch...

SCAI 2025: SAPT after TAVI should be considered “standard of care”

Single antiplatelet thera...

CX 2025: Managing blood pressure with medical therapy may play a role in limiting AAA growth

Results from the Cent...

CX 2025: Bioresorbable scaffold technology has ‘potential to be a new paradigm for femoropopliteal endovascular intervention’

In Wednesday's peripheral...

Edwards’ Sapien 3 lands US FDA approval for the treatment of asymptomatic severe AS

Edwards Lifesciences ...

Virtue trial to compare sirolimus and paclitaxel DCB technologies

Orchestra BioMed Holdings...

STS launches risk calculator for ascending aorta and aortic root surgery

The Society of Thoracic S...

SoloPace announces US FDA clearance and first-in-human use of TAVI temporary pacing system

SoloPace Incorporated has...

Transverse Medical completes first patient series involving Point-Guard CEP device

Transverse Medical has an...

PerQseal Elite vascular closure system gains CE mark

Vivasure Medical has anno...

Atrioventricular interval modulation therapy granted US FDA breakthrough designation

Orchestra BioMed Holdings...

Eight-year data “encouraging” for aortic valves using Resilia tissue technology

Edwards Lifesciences has ...

Terumo brings Medis QFR 3.0 to US market

Terumo Health Outcomes (T...

Edward Lifesciences’ Sapien M3 transfemoral mitral valve system gains CE mark

Edwards Lifesciences ...

FFR-guided PCI catches up to CABG at five years in FAME 3 study

Five-year results of ...

First cases performed with AtriClip PRO-Mini LAA exclusion system

AtriCure has announced th...

Elixir Medical launches LithiX Hertz Contact IVL system in Europe

Elixir Medical has announ...

Trial results open door to frozen plasma alternative for bleeding management in cardiac surgery

Four-factor prothromb...

STRIKE-PE interim analysis shows benefit for acute PE patients with syncope

A STRIKE-PE interim a...

“Sustained” clinical benefits seen at six months in Altavalve early feasibility study

Results of the Altava...

HighLife granted US FDA breakthrough designation for TMVR system

HighLife SAS has announce...

US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE

The US Food and Drug Admi...

Shockwave commences trial of Javelin IVL catheter in complex coronary disease

Shockwave Medical, pa...

Post-TAVI pacemaker implantation linked to long-term increase in mortality rates

Pacemaker implantatio...

DurAVR transcatheter heart valve reaches 100 patients

Anteris Technologies ...

ACC.25: Low-dose colchicine seen to reduce coronary plaque progression in EKSTROM trial

Low-dose colchicine (0.5m...

CONFORM IDE trial reaches enrolment milestone

Conformal Medical has...

Lancet Commission urges reframing of coronary disease towards atherosclerosis

Experts in the treatm...

Teleflex announces US FDA clearance for AC3 Range intra-aortic balloon pump

Teleflex has announced US...

ACC.25: ECLIPSE study results support routine use of intravascular imaging during PCI of calcified lesions, investigators say

Using intravascular i...

ACC.25: TEER with Triclip reduces heart failure hospitalisation versus medical therapy among TR patients in TRILUMINATE trial

Patients undergoing t...

ACC.25: Studies evaluate aortic stenosis referral and detection

Edwards Lifesciences ...

Early feasibility study of Siegel 8Fr TAVI valve launches

MiRus has announced t...

ACC.25: ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation

Data from 500 patient...

ACC.25: Evolut Low Risk trial shows comparable rates of all-cause mortality and stroke with TAVI and surgery at five years

Latest data from the ...

ACC.25: Cerebral embolic protection found not to reduce stroke in BHF PROTECT TAVI trial

Use of cerebral embol...

ACC.25: Semaglutide improves walk distance for PAD patients with diabetes

Semaglutide significa...

ACC.25: Bentracimab can reverse bleeding complications linked to ticagrelor

An investigational mo...

ACC.25: Rivaroxaban “a viable alternative to warfarin” in STEMI patients with left-ventricular thrombus

At three months of fo...

Preliminary IDE trial results demonstrate efficacy of dedicated device for coronary perforations

Teleflex has announced th...

CRT 2025: New TAV-in-SAV data underline importance of aortic valve sizing at index procedure

New data on the outco...

New funding to support expansion of clinical programme for Supira Medical pVAD

Supira Medical has announ...

PMcardio STEMI AI ECG tool earns US FDA breakthrough device designation

Powerful Medical has been...
Evident Vascular

Evident Vascular raises Series B financing to advance AI-powered IVUS platform technology

Evident Vascular has anno...

Abbott to begin TECTONIC trial of IVL therapy prior to coronary stenting

Abbott has announced ...

Cardiac Dimensions secures financing to complete EMPOWER trial

Cardiac Dimensions ha...

CRT 2025: First-in-human cases using robotic-assisted TMVR system performed in Chile

Details of the succes...

GE HealthCare launches AltiX AI.i editions of its Mac-Lab, CardioLab and ComboLab systems

GE HealthCare has announc...

SMARTFLOW study to assess diagnostic accuracy of AI-powered angiography image interpretation software

AngioInsight has announce...

Protembis names four-person advisory board

Protembis has announc...

CRT 2025: AGENT IDE trial results “consistent” out to two years using DCB in ISR

Consistent results ha...

Research project seeks to update cardiovascular risk calculations using latest technology

Robert Wood Johnson U...

Laplace Interventional closes series C financing round

Laplace Interventiona...

Valcare Medical receives US FDA approval to initiate EFS for Amend transseptal system

Valcare Medical has a...

CRT 2025: Acurate neo2 shows “reassuring” performance in observational study after stuttering IDE trial

Observational data fr...

Global Cardiovascular Awards – The full list of winners and highly commended entries

Best Cardiovascular...

Innovation and excellence celebrated at second Global Cardiovascular Awards

One of interventional car...

Howard Herrmann appointed CMO for structural heart by Affluent Medical

Affluent Medical has ...

CRT 2025: ATTENUATE trial shows significant radiation reduction in cath lab procedures using protective drape

A large single-centre...

CRT 2025: Improved haemodynamics seen with supra-annular TAVI system at two years in SMART trial

Two-year results of t...

CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs

A real-world study of...

Josep Rodés-Cabau named as editor-in-chief of Structural Heart

The Cardiovascular Re...

Reflow Medical expands global reach with new European subsidiary

Reflow Medical has announ...

Boston Scientific among investors in latest financing round for 4C Medical Technologies

4C Medical Technologies h...

SCAI highlights cath lab radiation and orthopaedic hazards

A survey conducted by...
heart attack

New partnership aims to develop platform for treating heart failure

Boston Scientific, Aj...

Shockwave Medical announces US launch of intravascular lithotripsy catheter

Today, Shockwave Medi...

Cadrenal Therapeutics and Abbott to collaborate on TECH-LVAD trial

Cadrenal Therapeutics...

Stereotaxis seeks to broaden use of its robotic magnetic navigation system into multiple endovascular fields

Stereotaxis has announced...

DeepQure advances clinical trials of its HyperQure extravascular renal denervation system

DeepQure has announce...

Boston Scientific to acquire renal denervation technology developer SoniVie

Boston Scientific has...

First US commercial cases performed with ShortCut leaflet modification device

Pi-Cardia has announc...

Pulnovo Medical closes series C financing round in support of two US FDA trials

Pulnovo Medical has annou...

DCB Days examines the new momentum in DCB-PCI

“This technique is he...

MyOme launches coronary artery disease polygenic risk assessment tool

MyOme has announced the l...

ACC and AHA acute coronary syndrome guidelines stress radial approach

The American College ...

Teleflex announce acquisition of Biotronik’s Vascular Intervention business

Teleflex has today announ...

Biotronik partners with Egg Medical to bring radiation protection systems to US healthcare workers

Biotronik is partnering w...

Medtronic commences Prevail Global study as it seeks coronary DCB approvals in USA and Japan

Medtronic has announced t...

First US centres use GE HealthCare’s Flyrcado cardiac PET imaging agent

GE HealthCare has del...

SCAI offers guidance on alternate access for TAVI

The Society for Cardiovas...

Drug therapy may slow progression of aortic valve stenosis

Researchers have demo...

Cardiovascular News – Issue 76 – February 2025: US Edition

In this issue: World...

Cardiovascular News – Issue 76 – February 2025: OUS Edition

In this issue: World...

Advertorial: DCB Days showcases new momentum in drug-coated balloon PCI

This advertorial is spons...

RANGO registry reports long-term safety and efficacy of Angiolite DES

iVascular has announced p...

Biotronik’s Freesolve resorbable scaffold to be studied in long lesions

Biotronik has announced t...

Bruno Scheller

Despite a complicated ear...

Sotagliflozin “shows new mechanism of action” in reducing heart attack and stroke among diabetics, kidney disease patients

Sotagliflozin, a rece...

Challenges of 21st century aortic education, innovation and evidence get top billing at CX 2025

Critical challenges i...

Economic analysis supports cost-effectiveness of Guardian monitoring system in high-risk acute coronary syndromes

Avertix Medical has annou...

THT 2025: eLym system “promising” for treatment of fluid overload in ADHF patients

WhiteSwell has announced ...

THT 2025: MODERATO II study demonstrates improved echo markers of diastolic dysfunction through AVIM therapy

Orchestra BioMed has ...

American Society of Echocardiography releases new guideline on ultrasound-guided vascular access

A new guideline from the ...

THT 2025: Reprieve system meets endpoints in FASTR randomised pilot study

Reprieve Cardiovascular h...

Coronary CT angiography-guided management of stable chest pains shows benefit out to 10 years

Coronary computed tom...

Heart teams digest role of early aortic intervention following EARLY TAVR and EVOLVED trials

Two trials delivered in l...

Studies add fuel to debate over choice of surgical or transcatheter strategies in dual treatment of aortic and coronary disease

A large-scale analysi...

DCB-PCI: What you need to know

In this video intervi...

Data and device tweaks herald ‘practice-changing’ future for bioabsorbable scaffolds

Pending the results o...

First experience of novel transseptal puncture device shared at STS 2025

First-in-human result...

Study weighs up discordance between bleeding risk calculation tools

A study assessing the per...

Lifemotion ECMO system receives CE mark certification

CBM Lifemotion has announ...

AVS completes US$36 million Series B financing ahead of IVL US commercial launch

Amplitude Vascular System...

Full IDE dataset from AMDS PRESERVE trial presented at STS 2025

Artivion has announced da...

EACTS launches grant scheme for heart valve care in underserved regions

A new outreach programme ...

STS 2025: Analysis sheds light on impact of surgeon preference in choice of multi- versus single-arterial grafting in CABG

In patients undergoing co...

Joseph Sabik elected STS president

The Society of Thoracic S...

STS 2025: Mechanical aortic valves “confer a significant survival advantage” in patients under 60

Mechanical aortic val...

Atraverse announces clinical evidence validating Hotwire radiofrequency guidewire system

Clinical evidence sup...

NFL stars to get HeartFlow analysis through GAMEFILM registry study

HeartFlow has partnered w...

First commercial cases using CrossFAST advanced delivery system performed in USA

Vantis Vascular has annou...

Accuryn monitoring system detects kidney injury in cardiac surgery patients “earlier than standard serum creatine criteria”

Research published in...

Caranx Medical makes US FDA submission for AI TAVI guidance software

Caranx Medical has an...

Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients

Researchers from Mass Gen...
FastWave

FastWave issued seventh utility patent for its IVL portfolio

FastWave Medical has ...

Humacyte files for investigational use of tissue engineered vessel in CABG

Humacyte has announced th...

US FDA announces plans to address medical device shortage risks

The US Food and Drug ...

Pivotal trial of dissolving film oral anticoagulant reaches completion

Taho Pharmaceuticals has ...

Advanced Bifurcation Systems secures latest round of funding

Advanced Bifurcation Syst...

Surgeons claim “world first” robotic artificial heart pump implant

King Faisal Specialis...

Circa announces successful first procedures with Crosswise RF transseptal access system

Circa Scientific has ...

Cardiac surgery societies endorse ESC coronary revascularisation recommendations

Four cardiac surgery soci...

Alleviant Medical secures funding for second pivotal trial of no-implant atrial shunt

Alleviant Medical has ann...

CMS launches review of coverage for renal denervation

The Centers for Medic...

Biotronik nets short DAPT and calcified lesion indications for Orsiro Mission DES

Biotronik has announced C...

CoreMedic and InnoRa partner to accelerate development of ChordArt mitral repair system

CoreMedic has entered int...

APEX-AV trial results of AlphaVac PE system published in JSCAI

AngioDynamics has announc...

AVENTUS trial of thrombectomy system for PE treatment completes enrolment

Inquis Medical has announ...

Piccolo Medical announces distribution agreement with Spectrum Vascular

Piccolo Medical has a...

Argon Medical enrols first patient in CLEAN-PE study

Argon Medical announces t...

First patients treated in TRICURE EFS study of Topaz tricuspid heart valve replacement system

TRiCares has announce...

Relief Cardiovascular closes financing round to fund first-in-human study

Relief Cardiovascular has...

Boston Scientific to acquire IVL developer Bolt Medical

Boston Scientific has...

Study finds adverse outcomes after decreased use of paclitaxel-coated devices

A recent analysis of ...

Simpson Interventions announces US FDA regulatory milestones

Simpson Interventions has...

Alleviant Medical to commence pivotal trial of no-implant atrial shunt in HFrEF patients

Alleviant Medical has ann...

US FDA issues first draft guidance for AI-based medical device development

The US Food and Drug Admi...

Harmony transcatheter pulmonary valve gains CE mark

Medtronic has received CE...

RevoEdge high-pressure coronary cutting balloon gains CE mark

BrosMed Medical has obtai...

Enrolment completed in ALL-RISE trial of FFRangio coronary physiology assessment

CathWorks has announc...

Invasive strategy does not reduce risk of cardiovascular death or non-fatal MI in older NSTEMI patients

A trial comparing an ...

Cardiovascular News’ most-read stories of 2024

Which stories, features a...

DCB is an effective option for PCI in patients with diabetes

Diabetes is one of th...

First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment

Reprieve Cardiovascular h...

First phase of BiVACOR early feasibility study completed

BiVACOR has announced the...

New evidence suggests fasting not needed before cardiac catheterisation procedures

A randomised trial te...

PCI should be standard of care in patients with coronary artery disease undergoing valve replacement

Performing percutaneo...

First patients enrolled in JENA-VAD registry

JenaValve Technology has ...

FastWave Medical closes $19 million financing round to advance IVL portfolio

FastWave Medical has ...
impella in preventing heart failure in stemi patients

Impella heart pump approved for use in paediatric patients

The US Food and Drug Admi...

Vantis Vascular completes series B financing round

Vantis Vascular has annou...

Developer of robotic heart valve system closes financing round

Capstan Medical has annou...

Initial shortlist for Global Cardiovascular Awards revealed

The initial shortlist for...

First-in-human study of Protaryx transseptal puncture technology completed

Protaryx Medical has anno...

Robotic aortic valve replacement offers an “exciting new chapter” in the treatment of aortic valve disease

The rapid growth of trans...

Terumo and Medis partner on coronary imaging technology

Terumo Health Outcomes (T...

Pilot study shows cryoablation safe and effective for patent foramen ovale closure in AF patients

New research suggests tha...

PCR London Valves 2024: Live cases at cardiology conferences “do not compromise patient safety”

Live cases broadcast ...

PERIGON trial demonstrates durability of Avalus aortic valve at seven years

Seven-year results of...

TCT 2024 hears early experience with high-definition IVUS system

Details of early stud...

PCR London Valves 2024: New data presented alongside launch of latest-generation Myval device

New analysis of the M...

FastWave issued sixth utility patent for its IVL portfolio

FastWave Medical has ...

WVU team performs pioneering combined robotic aortic valve replacement and coronary bypass procedure

The multidisciplinary...

PCR London Valves 2024: Medtronic shares Evolut cusp overlap and PVL data

Medtronic has announc...

Heart Valve Voice marks 10-year milestone

The UK charity for patien...

Scottish centres adopt on-screen system for endoscopic vessel harvesting

A Glasgow-based company h...

Abbott launches its largest Navitor Vision valve size in UK

Abbott has introduced...

Health Canada approves Wegovy for non-fatal MI reduction

Novo Nordisk announce...

ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI

“Disappointed is an u...

First patient procedures performed with Abbott’s balloon-expandable TAVI system

Abbott has announced ...

PCR London Valves 2024: One-year data affirm clinical performance of Sapien 3 Ultra Resilia TAVI system

One-year data highlig...

Attention turns to multi-organ denervation as new evidence supports “durability” of blood pressure reductions

New research will inv...

EACTS past president puts innovation and inclusivity at the top of the agenda

The immediate past pr...

CAPTURE-1 study of EmStop embolic protection system concludes

EmStop has announced the ...

First patients enrolled in high-risk PCI study of Supira pVAD

Supira Medical has announ...

AHA 2024: Five-year Amulet IDE data show similar outcomes with Amplatzer and Watchman devices

Latest data from the ...

First patient enrolled in trial of Cysoni temporary pacing technology

Ceryx Medical has announc...
heart attacks

ALERT study to use AI to identify underserved patients eligible for TAVI

Medtronic has announc...

Second Heart Assist announces further high-risk PCI cases using Whisper mechanical circulatory support device

Second Heart Assist h...

AHA 2024: OPTION trial reports positive outcomes for Watchman FLX at three years after AF ablation

Three-year results fr...

AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery

Edoxaban may be an effect...

AHA 2024: Spironolactone misses primary endpoints in CLEAR SYNERGY trial

Routine use of the bl...

Rafael Sádaba

Hailing from Pamplona, no...

Advertorial: Newest-generation TAVI platforms designed to meet the demands of the modern cath lab

This advertorial is spons...

Cardiovascular News – Issue 75 – November 2024: OUS Edition

In this issue: Early...

Cardiovascular News – Issue 75 – November 2024: US Edition

In this issue: Early...

BrightHeart gains US FDA clearance for AI ultrasound software for detecting congenital heart defects

BrightHeart has received ...

What they don’t teach in fellowship: Business insights for young cardiologists

Interventional cardio...

Early valve replacement falls short in EVOLVED trial

The question of early...

Orbital atherectomy fails to eclipse balloon angioplasty in randomised trial in severely calcified lesions

The routine use of or...

Trilogy valve shows favourable results at two years in aortic regurgitation patients

Latest data from the ...

CONFIRM-2 registry demonstrates use of AI-enabled quantitative CT for predicting MACE

Late-breaking study r...

Initial results of Sikelia transcatheter heart valve shared at TCT 2024

MitrAssist Lifesciences h...

CABG shows benefit over PCI in patients with diabetes and multivessel disease in Swedish registry study

Coronary artery bypas...

Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies

Shockwave Medical, pa...

Two-year LIFE-BTK data show sustained benefits of drug-eluting resorbable scaffold for below-the-knee arteries

Presented today, late...

US FDA approves IDE application for Katana thrombectomy system

The US Food and Drug Admi...

First patient enrolled in study of integrated laser atherectomy and IVL catheter

Royal Philips has announc...

TCT 2024: Drug-eluting resorbable scaffold proves cost effective at one year in LIFE-BTK analysis

A retrospective econo...

CMS grants transitional pass-through payment for Medtronic’s Symplicity Spyral and Recor’s Paradise renal denervation systems

The Centers for Medicare ...

TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system

One-year outcomes of ...

TCT 2024: Six-month data reflect safety and efficacy of Lithix HC-IVL system

Six-month data from t...

TCT 2024: TRISCEND II reports positive outcomes for tricuspid replacement system

The Evoque (Edwards L...

TCT 2024: New analysis shows difference in rates of stroke among US and non-US cohorts of PROTECTED TAVR trial

New analysis of the P...

TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation

Medtronic has announc...

TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE

Findings from the fir...

TCT 2024: One-year data from SIRONA trial show similar results for sirolimus versus paclitaxel DCB

Data from the prospec...

TCT 2024: New evidence could prompt rethink over use of colchicine following acute MI

The largest trial to ...

TCT 2024: PATCH study reports initial positive results for sutureless vascular closure system

Vivasure Medical has ...

TCT 2024: Non-invasive ultrasound therapy device shows promise in calcific aortic stenosis

The Valvosoft non-invasiv...

TCT 2024: Coronary bioadaptor shows clinical benefit in complex PCI sub-groups

Late-breaking data fr...

TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis

EARLY TAVR lived up t...

EMPOWER CAD all-female IVL trial completes enrolment

Shockwave Medical has ann...

TCT 2024: TAVI does not shift the dial in heart failure patients with moderate aortic stenosis

Transcatheter aortic ...

TCT 2024: Adjustable valve replacement system wins Shark Tank innovation prize

Symbiosis, the develo...

Adona interatrial shunt used in first human cases

Adona Medical has ann...

TCT 2024: Seven-year registry data confirm use of AI-enabled FFRCT

HeartFlow has announc...

First US cases performed with Vertex PE system in SPIRARE II pivotal study

Jupiter Endovascular has ...

First-in-human results for dual-drug therapy DCB released

Advanced NanoTherapie...

TCT 2024 live blog

Medtronic receives US FDA approval of Affera mapping and ablation system and Sphere-9 catheter

Medtronic has announc...

First patients treated with Duo tricuspid coaptation system in TANDEM II study

CroíValve has announced t...

NICE recommends use of HeartLogic heart failure diagnostic

Boston Scientific has ann...

Medtronic’s Evolut FX+ TAVI system gains CE mark

Medtronic has receive...

First-in-human implants with Luna TMVR system completed

Tioga Cardiovascular,...

Medtronic’s Prevail DCB to be studied in US IDE trial

Medtronic has received ap...

Gentuity HF-OCT imaging system receives FDA clearance

Gentuity has announced th...

COVID-19 infection may increase risk of heart attack up to three years later

An analysis of data in th...

Study highlights mortality disparity among minority patients undergoing CABG

Black patients are 22% mo...

EACTS 2024: Robotic aortic valve replacement shows promise as an alternative to TAVI

Robotic aortic valve ...

MedTech Innovation Forum returns at TCT 2024

Pressing issues in me...

Kaminari Medical closes €3.8 million financing round to advance intravascular imaging system

Kaminari Medical has ...

Ian Meredith joins board of directors at Transverse Medical

Transverse Medical ha...

EACTS 2024: Digital “prehabilitation” programme reduces adverse events after cardiac surgery

Patients awaiting car...

J&J completes acquisition of V-Wave

Johnson & Johnson...
AI

AI-based aortic stenosis screening software gains US FDA breakthrough designation

AccurKardia has announced...

Pivotal trial of AltaValve TMVR system commences in USA and Europe

4C Medical Technologies h...

EMBLOK enrols 50th patient in TAVI embolic protection trial

EMBLOK has announced ...

FASTR trial of Reprieve system completes enrolment

Reprieve Cardiovascular h...

ESC 2024: Chronic coronary syndrome guidelines clarify role of revascularisation and strengthen imaging recommendations

The European Society of C...

Randomised trial results support pausing anticoagulation prior to TAVI

Patients undergoing t...

AtriCure’s launches EnCompass clamp in Europe

AtriCure has received reg...

GLACE study to assess ICE imaging during LAA closure

Conformal Medical has...

US FDA clears Elucid’s PlaqueIQ imaging analysis software

Elucid has received 510(k...

Advertorial: Stent overexpansion is key to overcoming variable diameter in complex PCI cases

This advertorial is spons...

HFSA 2024: Aficamten shows improvement in clinical markers used to inform HCM care

Cytokinetics has announce...

HFSA 2024: One-year data from PROACTIVE-HF show reduction in heart failure hospitalisation and all-cause mortality

Endotronix has announ...

Three-year data from ASSURED study of Cardioform ASD occluder released

Gore has announced th...

Renal denervation gains class IIb recommendation in ESC guidelines

Latest guidelines fro...

ShortCut leaflet splitting device gains US FDA market clearance

The US Food and Drug ...

US FDA approves Flyrcado injection PET radiotracer for diagnosis of coronary artery disease

GE HealthCare has announc...

Medtronic launches VitalFlow ECMO system

Medtronic has announc...

Meta-analysis supports DAPT de-escalation after PCI

De-escalation to tica...
heart attacks

UK societies call for concerted effort to tackle cardiovascular disease in women

Concerted efforts are...

SSCORE registry of super saturated oxygen therapy in LAD STEMI patients begins

Zoll has announced that t...

Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions

A pooled analysis of thre...

Latest TRILUMINATE and TRI.Fr data add to growing body of evidence for tricuspid TEER

Data continue to emer...

Cerenovus and Biosense Webster among brands newly incorporated into Johnson & Johnson MedTech

Johnson & Johnson (J&...

First Topaz tricuspid valve implanted in European pivotal study

TRiCares SAS has announce...

TEER non-inferior to surgery in MATTERHORN trial but dividing lines remain

Investigators of a tr...

First cases completed in SPIRARE I trial with Vertex system

Jupiter Endovascular ...
AI

AI powered structural heart planning software gains US FDA clearance

Dasi Simulations has anno...

PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

PlaqueTec and RxCelerate ...

Novostia announces new funding and leadership changes

Novostia has announced a ...

Philips announces US FDA approval for enhanced LumiGuide guidewire, marks 1,000th patient treated with 3D device guidance technology

Royal Philips today a...

No-touch graft harvesting technique shows “no benefit, but significant harm” in SWEDEGRAFT study

A multicentre, regist...

Robotic PCI: TESLA registry demonstrates high clinical success rate for robotic platform

Insights from the TESLA...

SpectraWAVE eyes commercial expansion of its HypreVUE intravascular imaging system

SpectraWAVE has annou...

Advertorial: DCB may be an appealing strategy in diabetic patients undergoing PCI

This advertorial is spons...

CorFlow completes series B funding round to evaluate therapeutic treatments for MVO using CoFl system

CorFlow Therapeutics ...

Brightflow SAS raises €16.5M in series A financing round

Brightflow SAS has an...

AI-powered point-of-care ultrasound system gains US FDA approval

AISAP, a medical tech...

First two TAVI procedures completed using Venus-Vitae valve in SMART ALIGN trial

Venus Medtech has ann...

ESC 2024: Coronary bioadaptor non-inferior to DES at one-year for TLF

The DynamX (Elixir Medica...

ESC 2024: New evidence suggests fasting not needed before cardiac catheterisation procedures

A randomised trial testin...

TestLive

ESC 2024: Invasive strategy does not reduce risk of cardiovascular death or non-fatal MI in older NSTEMI patients

A trial comparing an inva...

ESC 2024: TAVI “superior” to surgery in women with severe aortic stenosis

The first trial comparing...

ESC 2024: “No need” for potassium supplementation after CABG

Supplementing potassi...

ESC 2024: RESHAPE-HF2 results move conversation forward on effectiveness of TEER in functional MR

A strategy of mitral tran...

New ESC guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity of whole arterial system

The European Society of C...

ESC hypertension guidelines stipulate conditions for renal denervation use

ESC guidelines on the man...

Will the NHS broaden its commissioning criteria for TEER?

Jonathan Byrne, consu...

ESC 2024: Remote echocardiograms offer “relatively good diagnostic accuracy”

Research presented at...
ESC 2024

ESC 2024 Congress live blog

First patient treated with AtriClip FLEX-Mini LAA device

AtriCure has announced th...

Acurate Prime TAVI system gains CE mark

Boston Scientific has...

ESC 2024: AI virtual voice assistant identifies complications after TAVI

Clinical follow-up us...

Brightflow appoints Sophie Humbert as CEO

Brightflow SAS has announ...

AtriClip LAA device receives expanded indication

AtriCure has received an ...

AI-based point-of-care ultrasound software gets US FDA clearance

AISAP has announced that ...

Nanox receives FDA approval for its latest generation AI platform for coronary disease detection

Nano X Imaging has announ...

Cardiovascular News – Issue 74 – September 2024: US Edition

In this issue: Is it...

Cardiovascular News – Issue 74 – September 2024: OUS Edition

In this issue: Is it...

Labelling change allows removal of aspirin following HeartMate 3 implant

Abbott has announced ...

SCOREPAD seeks to address “alarmingly high” mortality in CLTI patients with underlying coronary disease

A new research letter...

SCOREPAD seeks to address “alarmingly high” mortality in CLTI patients with underlying coronary disease

A new research letter...
renal denervation

Money-maker or meritable: Is renal denervation out of retirement?

In a paper published in t...

“There’s no meeting like it”: Stage is set for CX Aortic Live 2024

A meeting centred aro...

Rasha Al-Lamee

Best known for her work...

Johnson & Johnson to acquire V-Wave

Johnson & Johnson...

AVS and Jacobs Institute partner on study of Pulse IVL system

Amplitude Vascular System...

Jupiter Endovascular secures multimillion dollar financing round

Jupiter Endovascular has ...

Genesis MedTech announces sale of JC Medical to Edwards Lifesciences

Genesis MedTech has sold ...

Medical advisory board appointed to lead innovation at Radiaction

Radiaction Medical has an...

Survey highlights complication rates among pregnant cardiology trainees

A survey among female car...

AI models have potential in heart team decision-making, but beware blindspots

Large language models...

BioCardia submits 510(k) approval for Morph DNA steerable introducer sheath family

BioCardia has submitted a...

NMPA approves SyMap renal denervation system for treatment of uncontrolled hypertension

China’s National Medical ...

Funding allows CroíValve to advance US early feasibility study of Duo tricuspid valve

CroíValve has closed a US...
heart attack

Trialists call for rethink over use of MACE as a primary endpoint in cardiovascular trials

Three noted cardiovas...

Ringer perfusion balloon catheter gains US FDA approval

Teleflex has announced US...

Research aims to understand training needs for left-handed cardiac surgeons

For the estimated one in ...

EU bank finances maker of ProtEmbo cerebral embolic protection system

The European Investment B...

SavvyWire pre-shaped pressure guidewire gains CE mark

Haemonetics Corporation h...

Bavaria joins board of directors at PECA Labs

PECA Labs has added J...

Diabetic PCI patients have a higher risk of stent failure without glycaemic control

An observational stud...

Texas Heart Institute performs first-in-human implantation of BiVACOR total artificial heart

The Texas Heart Insti...

AMEND TS EU pilot study of mitral valve repair device expands to Italy

Valcare Medical has a...

First patients treated in US GPS study of Paradise renal denervation system

The first patients in...

SoniVie announces advancements in its renal denervation programme

SoniVie, which has develo...

Abbott’s Navitor Vision TAVI valve rolled out in UK and Ireland

Abbott is rolling out...

Edwards Lifesciences continues acquisition spree, announcing JenaValve and Endotronix deals

Edwards Lifesciences has ...

Prevencio receives US patent for AI-powered test of obstructive coronary artery disease

Prevencio has been issued...

Latest round of funding secured to boost clinical programmes for Topaz tricuspid valve system

TRiCares SAS has anno...

Funding secured to support clinical study of Elevate heart pump

Magenta Medical, deve...

AtriClip LAA exclusion system granted approval for marketing in China

AtriCure has received reg...

RSA-pace study of Cysoni-XT temporary pacing system granted approval

The UK Medicines and Heal...

Royal Brompton Hospital installs UK’s first Magnetom Cima.X MRI system

Royal Brompton Hospit...

ContraBand pulmonary artery banding system gains US FDA breakthrough status for HFrEF treatment

Restore Medical has been ...

Elucid begins site recruitment for PRE-VUE CT study

Elucid has initiated site...

Materialise announces FEops acquisition to offer “interactive” planning for structural heart procedures

Materialise, a provid...

New publication highlights performance of iVascular’s Essential pro DCB

iVascular has announc...

Consumer wearables found to have clinical value in assessing treatment for AF and heart failure

Monitoring of heart rate ...

How using DCBs can “open up a new world” for PCI

Early exposure to the...

First US heart failure patient receives V-LAP left atrial pressure sensor

A patient in Cincinna...

Edwards Lifesciences to acquire TMVR developer Innovalve

Edwards Lifesciences has ...

NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valves?

Ole De Backer (Copenhag...

Health Canada grants approval for use of Pascal Precision to reduce significant, symptomatic MR

Edwards Lifesciences has ...

Global Cardiovascular Awards return in 2025

Entries have opened for t...

TruLeaf Medical to commence clinical trial of RoseDoc two-stage TMVR system

TruLeaf Medical has r...
heart attacks

New research highlights sex disparity in treatment of CABG patients

Women over the age of...

MANIFEST-17k registry shows promising safety performance for PFA

Pulsed field ablation...

Adona Medical secures financing to initiate clinical use of interatrial shunt device

Adona Medical has sec...

US FDA approves Cordis’ Mynx Control venous vascular closure device

Cordis recently announced...

Creating an ecosystem for innovation in medtech

 At this year’s EuroP...

Financing secured to develop “personalised” tricuspid repair system

StarTric has finalised a ...

Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device

Investment in a programme...

Orsiro Mission DES available in expanded maximum allowed diameters range

Biotronik has announced t...

Anteris Technologies and v2vmedtech reach concept lock on VClip TEER system

Anteris Technologies and ...

DEEPER CORONARY trial of Spur system for coronary in-stent restenosis gets underway

Reflow Medical has announ...

First patients enrolled in study of pulmonary artery denervation treatment

Pulnovo Medical Limited h...

Valcare Medical appoints scientific advisory board to guide development of mitral annuloplasty device

Valcare Medical has a...

CardioFlow’s second-generation TAVI system gains CE-MDR certification

MicroPort CardioFlow Medt...

FASTIII trial of angiography-based vessel fractional flow reserve completes enrolment

Pie Medical Imaging has a...

DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation

Elixir Medical has an...

Cordis announce positive 24-month results from Selution SFA Japan trial

Cordis has announced posi...

Cardiac-MRI data from DurAVR FIH study shared at New York Valves

Cardiac magnetic reso...

Six-month TANDEM I results “promising” for Duo tricuspid coaptation system

Six-month results fro...

DeepQure receives IDE approval of extravascular renal denervation system to treat resistant hypertension

DeepQure, a Seoul bas...

Biopolymer surgical mitral valve sees favourable results at 30 days

Thirty-day results fr...

Abbott receives CE mark for Aveir dual chamber leadless pacemaker system

Abbott has received CE ma...

First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024

Initial experience wi...

Investigators find small reduction in disabling stroke from embolic protection device use

Analysis of data from...

New York Valves hears five-year data from PARTNER trials focused on small annulus patients

Results of an analysi...

Edwards Lifesciences to strengthen structural heart business after sale of Critical Care group

Edwards Lifesciences has ...

HighLife to initiate US pivotal study of transseptal mitral valve replacement system

HighLife SAS has announce...

First patients treated in pilot study of Half Moon TMVR device

Half Moon Medical has...
Shockwave Medical

Johnson & Johnson completes acquisition of Shockwave Medical

Johnson & Johnson tod...

First transseptal TMVR with Saturn valve performed in CASSINI-EU study

InnovHeart has announced ...

Terumo Cardiovascular gains US FDA clearance for CDI OneView monitoring system

Terumo Cardiovascular...

FastWave Medical announces successful 30-day first-in-human data on peripheral IVL technology

FastWave Medical has ...

Valentin Fuster given WHF Lifetime Achievement Award

Valentin Fuster, pres...

US FDA gives breakthrough device designation for lipoprotein blood test

Roche has announced that ...

BIOMAG-I two year results confirm safety and efficacy of Biotronik resorbable magnesium scaffold

New two-year follow-u...

EuroPCR 2024: Coronary implant with “site-specific” antithrombotic delivery shows promise at one year

Twelve-month outcomes...

First patients enrolled in AMEND TS pilot study

Valcare Medical has annou...

EuroPCR 2024: Leaflet splitting device may offer efficient option for avoiding coronary obstruction during valve-in-valve procedures

Insights from the investi...

GE Healthcare and Medis Medical collaborate to commercialise QFR technology

GE HealthCare and Med...

EuroPCR 2024: Coronary bioadaptor system shows sustained reduction of TLF at two years in BIOADAPTOR RCT

Two-year results from...

Anteris Technologies reports successful deployment of DurAVR in challenging valve-in-valve case

Anteris Technologies has ...

EuroPCR 2024: SMART trial data offer new insight on TAVI device choice in women

Data from the SMART t...

EuroPCR 2024: TAVI device with intermediate sizing shown to be non-inferior to contemporary platforms in LANDMARK trial

Early outcomes follow...

EuroPCR 2024: NOTION-2 one-year results prompt questions over TAVI in young, low-risk patients with bicuspid aortic valves

Analysis of one-year ...

CathWorks’ FFRangio system gains approval under EU MDR

CathWorks has announc...

First patient enrolled in BIOMAG-II trial of Freesolve resorbable scaffold

Biotronik has announced t...

Global Heart Hub shares findings from the Patients living with Elevated Cholesterol data programme

Global Heart Hub, an inte...

IVUS-guided PCI comes out on top over angiography in trial in acute coronary syndrome patients

In patients with acut...

Women and black patients less likely to receive catheter-based treatment for pulmonary embolism

New data from the REA...

Medtech Insights: Transcatheter tricuspid therapies “on the cusp of becoming standard of care”

The advance of transc...

Edwards’ Sapien 3 Ultra Resilia valve gets European launch

Edwards Lifesciences ...

AltaValve granted US FDA breakthrough device designation

4C Medical Technologi...

Advertorial: Handheld ultrasound: Providing a window into patients’ hearts at the point of care

This advertorial is spons...

Two-year echocardiographic data from REDUCE LAP-HF II trial published in JAMA Cardiology

Corvia Medical has an...

Patient wellbeing and satisfaction improve without drop in safety after non-fasting strategy prior to cardiac catheterisation

Findings from the CALORI ...

Advertorial: TAVI in small aortic annuli: SMART trial underscores importance of choosing the right device

This advertorial is spons...

US analysis demonstrates superiority of radial access for PCI

New data demonstrate ...

Nicolas Dumonteil

Medicine and indeed i...

Cardiovascular News – Issue 73 – May 2024: US Edition

In this issue: Late-...

Cardiovascular News – Issue 73 – May 2024: OUS Edition

In this issue: Late-...

SCAI 2024 hears additional analysis from SMART trial

Additional analysis f...

Medtronic’s Symplicity Spyral system approved for use in China

Medtronic has announc...

EACTS launches Innovation Hub to boost investment in surgical innovation

The European Associat...

PCI for stable coronary artery disease can be performed safely before, during or after TAVI

Percutaneous coronary int...

Atrial fixation TMVR device may have reduced risk of LVOT obstruction

Results of the early ...

Performance of single-piece biomimetic transcatheter heart valve “encouraging”, first-in-man results indicate

Insights from the fir...

Wattson temporary pacing guidewire begins limited market release

Teleflex has announced th...

Abbott’s Esprit BTK scaffold system given US FDA approval for CLTI treatment

Abbott has announced that...

STS updates risk calculators for tricuspid surgery, CABG and SAVR after TAVI

The Society of Thoracic S...

Medtronic announces US launch of Avalus Ultra surgical aortic valve

Medtronic has announced t...

AATS joins as surgical partner of New York Valves meeting

The American Association ...

Biotronik to distribute Texray radiation protection products

Biotronik has announc...

MAGICAL-ISR study of MagicTouch sirolimus DCB commences

Concept Medical has annou...

CX 2024: Paclitaxel device restrictions “did cause harm”

“Unfortunately, we ar...
Tria

Tria valves surpass 200 patient life years

Foldax has announced ...

Fastwave Medical issued fourth utility patent for laser-IVL platform

FastWave Medical has anno...

Acolyte system for guidewire positioning and placement in CTOs given US FDA breakthrough device status

Simpson Interventions has...

Caranx Medical announces successful robotic TAVI procedure in an animal

Caranx Medical has announ...

Olivier Pierron joins Cardiawave SA as chief executive officer

Cardiawave SA has appoint...

First large bore venous patient treated with PerQseal Elite vascular closure system

Vivasure Medical has anno...

Transverse Medical restructures board as it seeks to bring cerebral embolic protection system to market

Transverse Medical, devel...
heart attack

Clinical study of CADScor system to identify non-obstructive coronary artery disease in chest pain patients gets underway

Acarix has announced ...

ACC 2024: Use of Impella CP may boost survival in STEMI patients with cardiogenic shock

Use of the Impella CP...

ACC 2024: ORBITA-COSMIC shows reduction in chest pain in angina patients receiving coronary sinus reducer, but questions still remain

People with chronic c...
heart attacks

Survey highlights lack of awareness of among women of heart valve disease and risk factors

Medtronic has unveile...

ACC 2024: Self-expanding valve comes out on top at one year in SMART trial comparing TAVI devices in small aortic annuli

Results of the SMART ...

ACC 2024: Interatrial shunt fails to meet primary endpoint in RELIEVE-HF trial

Patients with heart f...

Johnson & Johnson to acquire Shockwave Medical

Johnson & Johnson is ...

ACC 2024: AEDs used in a small number of cardiac arrest cases, despite proximity

Automated external de...

One in 10 deaths after PCI found to be “preventable”, US state-wide analysis suggests

Around 10% of all deaths ...

AI software integrated into GE Healthcare’s Vscan Air SL handheld ultrasound imaging system

GE HealthCare has ann...

Leadership change at TRiCares sees Atricure and Medtronic veteran join as president and CEO

TRiCares has announce...

Alain Cribier remembered by heavyweights of TAVI

Michael Reardon and L...

Debates to unpick controversies in aortic repair at CX 2024

Debates will shed new...

TriClip TEER system for TR repair given US FDA approval

Abbott has announced that...

PROTEMBO randomised trial of three-vessel cerebral embolic protection device enrols first patient

Protembis has announced t...

Winrevair given US FDA approval for the treatment of pulmonary arterial hypertension

Merck has announced the U...

Cardiac surgeon and interventional cardiologist join egnite’s medical advisory board

egnite, a digital health ...

Latest-generation Evolut TAVI system gains US FDA approval

Medtronic has announc...

US registry launches to evaluate physician decision-making using HeartFlow Plaque Analysis

HeartFlow has announced t...

ENVISION trial of Abbott’s Navitor TAVI valve in low-risk patients enrols first patient

Abbott has announced that...

CRT 2024: Shield system cuts operator exposure to radiation during cath lab procedures

The use of a radiatio...

CRT 2024: US DCB approval provides “important treatment option” for in-stent restenosis

The first US Food and...

Robotic system “brings transcervical aortic valve replacement a step closer”

A company specialising in...

BioCardia announces long-term partnership with StemCardia

BioCardia and StemCardia ...

Health Canada licenses Symplicity Spyral radiofrequency renal denervation system to treat hypertension

Medtronic has received a ...

Funding round closes in support of ConKay annuloplasty system for TR treatment

ConKay Medical Systems, a...

Global Cardiovascular Awards – The full list of winners and highly commended entries

Best Cardiovascular...

Past, present and future of cardiovascular innovation celebrated at Global Cardiovascular Awards

A founding father of ...

Cost-effectiveness and updated efficacy data from Evolut Low Risk trial shared at CRT 2024

Medtronic has announc...

Gilbert Tang named as editor-in-chief of JACC: Case Reports

Cardiothoracic surgeo...

Customising PCI with DES and DCB

This educational suppleme...

ADVERTORIAL: TAVI offers promise in the “underdiagnosed and undertreated” aortic regurgitation population

This advertorial is spons...

HeartFlow shares ten-year data from DISCOVER-FLOW study

HeartFlow has announc...

First mitral valve replacement performed using SSi Mantra robotic system

SS Innovations Internatio...

CRT 2024: SAFE-MCS finds reduction in bleeding for high-risk PCI patients with bleed monitoring system

Saranas has announced res...
Sapien 3

CRT 2024: New data on outcomes with Sapien TAVI platform

Results from two larg...

US FDA approves weight loss drug Wegovy to prevent cardiovascular events

The US Food and Drug ...

PulseCath’s iVAC 2L gains MDR certification

PulseCath has announced t...

Cleerly receives US FDA breakthrough designation for CAD staging system

Cleerly has been granted ...

PROACTIVE-HF pivotal trial of Cordella pulmonary artery sensor meets primary endpoints

Six-month results fro...

Trial of autologous cell therapy in advanced chronic heart failure reports interim results at THT 2024

BioCardia has announced i...

FastWave Medical gains third patent from USPTO for IVL system

FastWave Medical has anno...

Mobile clinical research specialist Hawthorne Effect appoints new CEO

Hawthorne Effect, a s...

Boston Scientific’s Agent DCB gains first US FDA coronary approval

Boston Scientific has ann...

EACTS and STS guidelines recognise aorta “as an organ in its own right”

New guidelines from t...

Philips launches new motorised mobile C-arm system

Royal Philips has ann...

Patient enrolment completed in study of remote heart failure monitoring device

FIRE1 today announced tha...
heart attack

First patient treated using A-Flux Reducer interventional system for angina

VahatiCor has announc...

Renal denervation finds new shores following US FDA device approvals

Like London buses, in...

Settling the paclitaxel versus sirolimus DCB debate

Bernardo Cortese (Fondazi...

Challenges establishing minimally invasive cardiac surgery in the developing world

Attaulah Khan Niazi (King...
Tria

Foldax agrees manufacturing agreement with Dolphin Life Science India

Foldax has announced ...

First cases using Laminar LAAX system performed as part of IDE study

Biosense Webster has anno...

Ismail El-Hamamsy named as president of Heart Valve Society

Ismail El-Hamamsy, di...

First procedure completed using Laplace tricuspid valve replacement system

Laplace Interventiona...

Philips announces LumiGuide 3D imaging technology availability in Europe and USA

Philips' LumiGuide ‘h...

Cardiovascular News – Issue 72 – February 2024: OUS Edition

In this issue: New d...

Cardiovascular News – Issue 72 – February 2024: US Edition

In this issue: New d...

Todd Berg joins NeoChord as CEO

NeoChord  has appointed T...

Ajay Kirtane

For Ajay Kirtane (Columbi...

Analyses provide “hard evidence” of benefit of intravascular imaging-guided PCI

Two meta-analyses com...

Australian government offers grant support to artificial heart programme

BiVACOR, a clinical-stage...

Reprieve Cardiovascular secures multimillion dollar financing

Reprieve Cardiovascular, ...

Global registry charts pandemic’s impact on TAVI volumes

Transcatheter aortic ...

Alain Cribier: 1945–2024

Alain Cribier, the pi...

TriClip gets positive vote from US FDA advisory panel

The Circulatory System De...

Biotronik’s Freesolve resorbable magnesium scaffold gains CE mark

Biotronik has announced t...

BHF PROTECT-TAVI trial poised to answer key questions about use of cerebral embolic protection during TAVI

Investigators behind ...

FLOWer embolic protection device gains CE mark

AorticLab has announced C...

Biotronik launches Micro RX microcatheter to the US market

Biotronik has launched th...
SonieVie

Study of TIVUS renal denervation system for hypertension treatment completes enrolment

The REDUCED-1 study, a US...
VenusP-Valve

Health Canada approves VenusP-Valve transcatheter pulmonic valve replacement system

Venus Medtech has announc...

Early feasibility study of TAVI platform for treatment of aortic regurgitation completes enrolment

Genesis MedTech has annou...

STS 2024: Large registry study demonstrates superiority of multi-arterial grafting for multivessel revascularisation

A study of more than ...

Evoque becomes first transcatheter tricuspid system to gain US FDA approval

Edwards Lifesciences ...
AI

AF Symposium 2024: AI-enabled predictive pre-planning “significantly improves LAAO procedural efficiency”

Data from the first US co...

Cast your vote for the Heart Team of the Year

Two specialist heart team...
123...7Page 1 of 7

Most read

Features

Profiles

Bernardo Cortese

Roxana Mehran

Patrick Myers

Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube